Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

Peer Review reports

Original Submission
7 Apr 2022	Submitted	Original manuscript
28 Apr 2022	Author responded	Author comments - Melanie Dos Santos
Resubmission - Version 2
28 Apr 2022	Submitted	Manuscript version 2
Publishing
29 Apr 2022	Editorially accepted
12 May 2022	Article published	10.1186/s12885-022-09623-z

Back to article page